91ÉçÇø

Antimicrobial Resistance (AMR)

This course will not be offered in 2024.

DESCRIPTION

The focus of this three-day course is on understanding the complex causes underlying the emergence and spread of AMR, on identifying practical approaches to tackle antibiotic misuse in different settings, and discussing promising scientific advances related to AMR.

COURSE DIRECTORS

Makeda Semret, MSc, MD, FRCPC

Associate Professor of Medicine, Infectious Diseases and Medical Microbiology, 91ÉçÇø
Lead, Antimicrobial Stewardship Program, MUHC
Director, Training Program in Infectious Diseases and Medical Microbiology, 91ÉçÇø
Associate Director, 91ÉçÇø AMR Centre

Erika Vlieghe MD
Head of the Department of General Internal Medicine, Infectious Diseases and Tropical Medicine, University Hospital Antwerp
Professor of Infectious Diseases, University of Antwerp

Dao Nguyen, MSc, MD, FRCPC
Associate Professor of Medicine, Microbiology and Immunology, 91ÉçÇø
Founder and Director, 91ÉçÇø AMR Centre

PREVIOUS COURSE FACULTY

• Alemseged Abdissa -Armauer Hansen Research Institute, Ethiopia
• Annelie Monnier – Radboud University Medical Center, the Netherlands.
• Bastien Castagner – 91ÉçÇø, Canada
• Cedric Yansouni – 91ÉçÇø, Canada
• Christian Lavallee -Université de Montréal, Canada
• Corinne Maurice – 91ÉçÇø, Canada
• Daniel de Vos - Queen Astrid Military Hospital, Belgium
• Dao Nguyen – 91ÉçÇø, Canada
• Erika Vlieghe – University Hospital Antwerp, Belgium
• Heiman Wertheim – Radboud University, Netherlands
• Ian Marr – Menzies School of Health Research, Australia
• Iruka Okeke – Nigerian Academy of Sciences, Nigeria
• Janne Vehreschild – German Centre for Infection Research (DZIF), Germany
• Jen Ronholm – 91ÉçÇø, Canada
• Jesse Shapiro – 91ÉçÇø, Canada
• Louis Valiquette – Université de Sherbrooke, Canada
• Louis-Patrick Haraoui – Université de Sherbrooke, Canada
• Makeda Semret – 91ÉçÇø, Canada
• Marcus Zervos – Henry Ford Health System, USA
• Pem Chuki – Khesar Gyalpo University of Medical Science, Bhutan
• Raffaella Ravinetto – Institute of Tropical Medicine Antwerp, Belgium
• Sam Gruenheid – 91ÉçÇø, Canada
• Senjuthi Saha- Child Health Research Foundation, Bangladesh
• Stephane Bayen – 91ÉçÇø, Canada
• Tessa Wyllie -Menzies School of Health Research, Timor Leste and Australia
• Tinsae Alemayehu -American Medical Center and St Paul Millennial Medical Hospital, Ethiopia
• Yves Longtin – 91ÉçÇø, Canada

Faculty are still being confirmed and there may be changes to the above list.

CONTENT

Antimicrobial resistance (AMR) is now one the biggest threats facing modern medicine. Initially described mostly in association with hospital-associated infections in high-income countries, the highest rates of AMR are now reported from low and middle-income countries (LMIC) around the world. The causes underlying the global rise in AMR are complex, but central to this crisis is overconsumption of antibiotics.

This 3-day hybrid course will focus on understanding the complex causes underlying the emergence and spread of AMR, on approaches to tackle antibiotic misuse in different settings, and on discussing promising scientific advances related to AMR.

The course format is a mix of plenary talks and panel discussions, with opportunities to interact with course faculty and participants who work across the spectrum of the antimicrobial resistance space indifferent countries.

Clinicians, researchers, implementers, and health educators from both high-income and low and middle-income countries will share questions, successes, and lessons learned to advance the field of AMR.

OBJECTIVES

At the end of this course, participants will be able to:

• Understand the basic mechanisms and trends in antimicrobial resistance
• Describe essential diagnostic tools and challenges/opportunities for improved AMR surveillance in different settings
• Identify adaptive challenges and practical solutions to implementing stewardship programs in different settings
• Understand the emerging issues in antimicrobial use and resistance in agriculture and natural environments, and their potential link to human health
• Discuss promising advances in AMR-related biomedical research

TARGET AUDIENCE

This course appeals to a wide range of participants including:

• Clinicians, pharmacists, technologists, researchers and students studying infectious diseases, tropical medicine, or global health
• Policy makers and public health agency officials
• Product developers and funders
• Community advocacy groups working in global health

ENROLMENT

In-person maximum 150 participants.

Online maximum 100 participants.

Ìý